Table 2 Antibiotic treatment for enterococcal, nutritionally‐variant and penicillin‐resistant (MIC >0.5 mg/l) streptococcal endocarditis.
| Condition | No allergy to penicillin | Allergy to penicillin | Duration | ||
|---|---|---|---|---|---|
| Drug | Dosage | Drug | Dosage | ||
| Enterococcal strain susceptible to penicillin, aminoglycosides, and vancomycin | Amoxicillin or | 200 mg/kg/d | Vancomycin | 30 mg/kg/d | 4–6 weeks† |
| penicillin G | 300–400 000 U/kg/d | or teicoplanin | 6–10 mg/kg/d | ||
| + gentamicin* | 3 mg/kg/d | + gentamicin* | 3 mg/kg/d | ||
| Enterococcal strain susceptible to penicillin, streptomycin, vancomycin, and resistant to gentamicin | Amoxicillin or | 200 mg/kg/d | Vancomycin | 30 mg/kg/d | 4–6 weeks† |
| penicillin G | 300–400 000 U/kg/d | or teicoplanin | 6–10 mg/kg/d | ||
| + streptomycin‡ | 15 mg/kg/d | + streptomycin‡ | 15 mg/kg/d | ||
| Enterococcal strain resistant to penicillin (intrinsic resistance), susceptible to gentamicin and vancomycin | Vancomycin | 30 mg/kg/d | Vancomycin | 30 mg/kg/d | 6 weeks |
| or teicoplanin | 6–10 mg/kg/d | or teicoplanin | 6–10 mg/kg/d | ||
| + gentamicin* | 3 mg/kg/d | + gentamicin* | 3 mg/kg/d | ||
| Enterococcal strain resistant to penicillin (β–lactam producing), susceptible to gentamicin and vancomycin | Co‐amoxyclav | 175 mg/kg/d amoxicillin | Vancomycin | 30 mg/kg/d | 6 weeks |
| + gentamicin* | 3 mg/kg/d | or teicoplanin | 6–10 mg/kg/d | ||
| + gentamicin* | 3 mg/kg/d | ||||
| Streptococcal and enterococcal strains with high‐level resistance to all aminoglycosides | Amoxicillin | >200 mg/kg/d | Vancomycin | 30 mg/kg/d | ⩾8 weeks |
| E faecalis resistant to penicillin, aminoglycosides and vancomycin | Amoxicillin | 200 mg/kg/d | − | − | ⩾8 weeks |
| + ceftriaxone or | 2 g/d | ||||
| imipenem | 2 g/d | ||||
| E faecium resistant to penicillin, aminoglycosides and vancomycin | Linezolid, or | 1200 mg/d | Linezolid, or | 1200 mg/d | ⩾8 weeks |
| quinupristin‐dalfopristin | 22.5 mg/kg/d | quinupristin‐dalfopristin | 22.5 mg/kg/d | ||
*Two or three daily doses.
†Duration of aminoglycoside administration could be shortened to 2–3 weeks; the total duration of treatment should be 6 weeks when vancomycin or teicoplanin are used.
‡Two daily doses.